Adalimumab for Nail Psoriasis: Efficacy and Safety From the Open-Label Extension of a Phase-3, Randomized, Placebo-Controlled Trial
SKIN The Journal of Cutaneous Medicine
doi 10.25251/skin.1.supp.96
Full Text
Open PDFAbstract
Available in full text
Date
October 27, 2017
Authors
Publisher
National Society for Cutaneous Medicine